What You Should Know:
- Twin Health, a company known for its Digital Twin™ AI platform that helps individuals achieve remission of type 2 diabetes, has announced promising results in a new study focused on hypertension.
- Published in the Journal of the American College of Cardiology, the study demonstrates that the platform can effectively help users control blood pressure and reduce their reliance on medication.
Addressing the Link Between Diabetes and Hypertension
High
Read More
Type 2 Diabetes - Chronic Disease Management | News, Analysis, Insights - HIT Consultant
POGO Automatic Blood Glucose Monitor Now Covered by Medicare Part B
What You Should Know:
- Intuity Medical, Inc., a medical technology company committed to making it easier to live with diabetes, announced today that its POGO Automatic® Blood Glucose Monitoring (ABGM) system, featuring one-step testing, is now covered by Medicare Part B. This decision expands access to the innovative monitor for the 16.5 million seniors age 65 and up living with
Read More
How Search Makes Clinical Natural Language Processing Useful in the Real World
Clinical Natural Language Understanding (cNLU), the technology by which computers extract meaning from clinical text, is quickly becoming a common feature in the healthcare IT landscape. In 2021, 30% of surveyed healthcare organizations were either using or exploring the technology. (Gradient Flow, 2021). Similar adoption is occurring in the UK as well. (Wu et. al, Nature, 2022). Today, cNLU is being applied to billing/coding, trial enrollment, registry creation, clinical decision support,
Read More
Ryse Health Secures $6.5M for Type 2 Diabetes Care
What You Should Know:
- Ryse Health, a healthcare technology company that’s committed to pursuing a world free from chronic diseases and raising the bar on Type 2 Diabetes care raises $6.5M in Series A funding led by Route 66 Ventures. The round also included support from W Health and Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShield.
- The company plans to use the funding to enable Ryse to continue to grow its team, strengthen its business operations, partner
Read More
Vida Health Expands its Cardiometabolic Capabilities
What You Should Know:
- Vida Health is expanding its solution for chronic conditions by adding the ability to prescribe and deprescribe glucagon-like peptide 1 (GLP-1) agonists for both type 2 diabetes and obesity for appropriate patients. As part of Vida’s value-oriented treatments for cardiometabolic conditions, patients with obesity and diabetes will now be candidates for GLP-1 therapy within the Vida platform.
- With the addition of GLP-1s and other obesity medications in higher acuity
Read More
Blood Sugar Monitoring Devices Pose Wearability & Use Problems for Older Diabetic Adults & Caregivers
What You Should Know:
- In an initial trial of continuous glucometer use, faulty device adhesive -- a serious wearability challenge -- and patient difficulty in interpreting graphs produced by the device, were noted. In a subsequent trial, 70 older adults with diabetes wore glucometers and activity monitors and used smartphones and electronic medication bottles to track and manage blood sugar over a two-week period.
- Among these 70 patients, two-thirds of whom were African American and
Read More
Blue Shield of California, Virta Health Partners to Reverse Type 2 Diabetes in California
What You Should Know:
- Blue Shield of California has expanded its partnership with Virta Health to help reverse the human and financial impact of type 2 diabetes in the state.
- The partnership marks Blue Shield as the first health plan in California to implement a digital diabetes reversal solution across multiple lines of business.
Blue Shield is first health plan in California to implement digital diabetes reversal solution across multiple lines of business.
As part of Blue
Read More
Omada Health, Intermountain, Castell to Establish Integrated, Virtual Care Option for Diabetes Management and Prevention
What You Should Know:
- Omada Health and Castell, an Intermountain value-based care subsidiary, announced a first-of-its kind partnership – creating a new, integrated virtual care model to reach and help more at-risk patients through proven prevention and Diabetes programs.
The new virtual care model expands the access of Omada’s Diabetes Prevention Program and Diabetes Program to patients and caregivers receiving care from Intermountain Healthcare’s primary care providers
Read More
NuraLogix Unveils Telehealth Platform Performing Continuous Health/Vital Signs During Video Calls
What You Should Know:
- NuraLogix, global pioneers of contactless health monitoring whose technology can take over 30 medical-grade health vitals using any video-enabled device, unveils Anura™ Telehealth, a platform that performs continuous health and vital sign measurements while on a video call.
- This is the latest addition to its AnuraTM platform that uses conventional video cameras to extract facial blood flow information to accurately calculate a host of medical vitals and health
Read More
Q/A: Podimetrics CEO Talks Preventing Diabetic Amputations
Diabetes prevention is one of the biggest challenges in the healthcare industry as more than 37 million Americans (11.3% of the population) suffer from this debilitating chronic disease. As we close the year out, we sat down with Jon Bloom, MD, CEO and Co-founder of diabetic healthcare tech company Podimetrics to learn how the industry and his company are working to implement health equity change to serve patients living with advanced diabetes. The company’s FDA-cleared SmartMat provides a
Read More
